VOLITION
LIVE

Serial Number

98208918

Owner

Belgian Volition SRL

Attorney

Amanda G. Hyland

Filing Date

Oct 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VOLITION Trademark

Serial Number: 98208918

VOLITION is a trademark filed by Belgian Volition SRL on October 4, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Belgian Volition SRL (3 trademarks)

9-13 St. Andrews Street
London EC4A3AF , th

Entity Type: 99

Trademark Details

Filing Date

October 4, 2023

Registration Date

Not Registered

Published for Opposition

October 14, 2025

Goods & Services

Chemicals and biological preparations used in industry and science; chemical and biological reagents for use in industry and science; diagnostic reagents for scientific and research purposes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests, for scientific purposes and not for medical or veterinary purposes; Reagents for scientific use in the field of life sciences; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); assays for testing stem cell differentiation status, other than for medical or veterinary use

Medical services and veterinary services; diagnostic medical testing and treatment of disorders, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, and disorders associated with neutrophil extracellular traps (NETs); medical analysis services relating to the treatment of persons and animals; health care; hospital services; Veterinary services, namely, advisory of medical, diagnostic or surgical services for animals; human tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical clinic services; medical screening; medical equipment rental; epigenetic testing for medical purposes, namely, for diagnosing disease, monitoring disease and treatment efficacy; medical analysis for the diagnosis and treatment of persons and animals; Medical and health care services in the field of DNA, genetics and genetic testing; genetic testing of animals for diagnostic or treatment purposes; DNA and RNA analysis services for medical purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnosis and prognosis in the field of diseases related to epigenetic and nucleosomal changes, namely cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); genetic testing for medical purposes; Blood analysis services for diagnostic purposes provided by medical laboratories; Veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories

Pharmaceutical, chemical, biological, medical preparations for treating diseases caused by epigenetic and nucleosomal changes, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); biological tissue cultures for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; chemical and biological reagents for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; Diagnostic reagents, preparations and substances for medical use in the field of epigenetics and nucleosomes; diagnostic reagents for medical and veterinary use; Diagnostic reagents for medical use for in vitro diagnosis; Diagnostic preparations for medical purposes for detection, monitoring and diagnosis of cancer, sepsis, Covid-19, infection, dementia, Alzheimer's disease, thrombosis, vascular damage and inflammation, autoimmune diseases, and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Pharmaceutical preparations for the treatment of conditions related to in vivo and ex vivo organ and tissue transplant; Medical diagnostic assays for stem cell differentiation status; blood for medical and veterinary purposes; blood plasma; cultures of microorganisms for medical and veterinary use; diagnostic biomarker reagents for medical and veterinary purposes; Transplants, namely, living human allograft tissue

Scientific and technological services, namely, custom design of chemical reagents and biological assays and research, all in the field of epigenetics and nucleosomes; Industrial research and scientific analysis in the field of epigenetics and nucleosomes; research and development services in the field of biotechnology, medical technology, assays, medical diagnostics, diagnostic reagents, substances, preparations and materials, detection of cancer and other diseases; scientific consulting in the field of research and development of biotechnology, medical technology, assays, medical diagnostic reagents, and technology for detecting cancer and other diseases; Providing analytical reagent sample testing and diagnostics services for others for scientific research purposes in the field of epigenetics and nucleosomes; Product design and development in the field of medical diagnostic testing apparatus and reagents; Blood analysis services for scientific research purposes; Veterinary research laboratory services; DNA and RNA analysis services for scientific research purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant health, thrombosis, vascular damage, inflammation, disorders associated with the immune system and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS)

Medical and therapeutic apparatus and instruments for use in treatment of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS) in humans and animals; Medical and veterinary devices for diagnosing cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs) pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for analyzing and measuring cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in the diagnosis, monitoring and treatment of cancer; medical apparatus, instruments and equipment for use in the monitoring and diagnosis of sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage and inflammation, disorders associated with neutrophil extracellular traps (NETs) and pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in monitoring the immune system, namely, for monitoring blood properties; Medical diagnostic apparatus for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for use with chemical and biological reagents, for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical apparatus for use in carrying out diagnostic assays; Medical apparatus, equipment and instruments for monitoring diseases namely, cancer sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); apparatus for DNA and RNA testing for medical purposes; Medical apparatus for use in regeneration of transplant tissues and organs; blood testing apparatus; dialyzers; apheresis devices for medical use; structural parts for all the aforesaid goods

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 15, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 11, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 19, 2025 GNFN
FINAL REFUSAL E-MAILED
May 19, 2025 GNFR
FINAL REFUSAL WRITTEN
May 19, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 7, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2025 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 7, 2025 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Nov 18, 2024 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 25, 2024 CNRT
ASSIGNED TO EXAMINER
May 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2023 NWOS
NEW APPLICATION ENTERED
Oct 7, 2023 NWAP